|
If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.
It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.
Wiley InterScience | ||||
  AddictionVolume 101 Issue 2, Pages 192 - 203 Published Online: 24 Jan 2006 Journal compilation © 2010 Society for the Study of Addiction Published on behalf of the Society for the Study of Addiction
Abstract | References | Full Text: HTML, PDF (Size: 164K) | Related Articles | Citation Tracking  REVIEW A meta-analysis of voucher-based reinforcement therapy for substance use disorders Copyright 2006 Society for the Study of Addiction KEYWORDS Contingency management • incentives • substance abuse treatment • vouchers ABSTRACTAims To systematically investigate the effectiveness of voucher-based reinforcement therapy for the treatment of substance use disorders. Methods Effect sizes and 95% confidence intervals were calculated for studies published between January 1991 and March 2004 that utilized voucher-based reinforcement therapy (VBRT) or related monetary-based incentives to treat substance use disorders (SUDs). Findings Thirty studies involved interventions targeting abstinence from drug use using experimental designs where effects on treatment outcome could be attributed to the VBRT intervention. The estimated average effect size (r) for those studies was 0.32 (95% CI 0.26–0.38). Analyses of variables thought to moderate VBRT effect sizes revealed that more immediate voucher delivery and greater monetary value of the voucher were associated with larger effect sizes. Additional studies were identified wherein VBRT was used to target clinic attendance (n = 6) or medication compliance (n = 4). VBRT studies targeting attendance produced average effect sizes of 0.15 (95% CI 0.02–0.28), while those that targeted medication compliance produced an average effect of 0.32 (95% CI 0.15–0.47). No significant moderators were identified for these 10 studies. Conclusions Overall, VBRT generated significantly better outcomes than did control treatments. These results further support the efficacy of VBRT, quantify the magnitude of its effects, identify significant moderators and suggest potential directions for future research. Submitted 5 January 2005; initial review completed 31 March 2005; final version accepted 22 July 2005 | 
|
